STOCKSCREENR
Log In

LAB

NASDAQ

Standard BioTools Inc.

$0.98+0.03(+3.01%)Mkt Cap: $378.30M

Key Stats

Market Cap

$378.30M

P/E Ratio

-6.56

EPS

$-0.15

Dividend Yield

0.00%

52-Week Range

$0.92 — $1.72

Volume

2.62M

Avg Volume

1.85M

Beta

1.37

Valuation

P/E (TTM)

-6.56

Forward P/E

—

PEG Ratio

-0.12

P/S (TTM)

4.20

P/B (TTM)

0.85

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.18%

ROA (TTM)

-0.13%

ROIC

—

Gross Margin

0.50%

Operating Margin

-1.09%

Net Margin

—

Debt/Equity

0.07

Current Ratio

4.19

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.35%

EPS Growth (5Y)

-0.17%

Sales Growth (3Y)

+0.16%

Sales Growth (5Y)

+0.12%

EPS Est (This Year)

$-0.12

EPS Est (Next Year)

$-0.10

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.49

Analyst Consensus

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

384.57M

Float

42.17M

Free Float %

10.97%

About

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

NASDAQ

IPO Date

2011-02-10

Employees

814

CEO

Michael Egholm

Index Membership

—

Website

https://www.standardbio.com

Standard BioTools Inc. (LAB) is a healthcare company in the medical - devices industry listed on the NASDAQ. With a market capitalization of $378.30M, a P/E ratio of -6.56, LAB is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare LAB against other stocks using dozens of fundamental and technical filters.

Similar Stocks

PRN.TO

Profound Medical Corp.

$8.02

+3.08%

$242.68M

AVNS

Avanos Medical, Inc.

$13.61

-1.52%

$632.91M

OFIX

Orthofix Medical Inc.

$12.03

+1.35%

$482.94M

AHCO

AdaptHealth Corp.

$10.45

+0.29%

$1.42B

IRMD

IRadimed Corporation

$102.80

+1.09%

$1.31B

VMD

Viemed Healthcare, Inc.

$9.69

-0.92%

$375.83M

Frequently Asked Questions

What is Standard BioTools Inc.'s P/E ratio?

Standard BioTools Inc. (LAB) has a trailing twelve-month (TTM) P/E ratio of -6.56. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Standard BioTools Inc. pay a dividend?

No, Standard BioTools Inc. (LAB) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Standard BioTools Inc.'s market cap?

Standard BioTools Inc. (LAB) has a market capitalization of $378.30 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.